Skip to main content
Publications
Vandenberghe F, Gholam-Rezaee M, Saigi-Morgui N , Delacretaz A, Choong E, Solida-Tozzi A, Kolly S, Thonney J, Gallo SF, Hedjal A, Ambresin AE, von Gunten A, Conus P, Eap CB. Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment . J Clin Psychiatry. 2015 Nov;76(11):e1417-23. doi: 10.4088/JCP.14m09358.
Delacretaz A, Preisiq M, Vandenberghe F, Saigi Morgui N , Quteineh L, Choong E, Gholam-Rezaee M, Kutalik Z, Magistretti P, Aubry JM, von Gunten A, Castelao E, Vollenweider P, Waeber G, Conus P, Eap CB. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in population-based subjects with present or past atypical depression . PLoS One. 2015 Oct 13;10(10):e0139155. doi: 10.1371/journal.pone.0139155
Saigi-Morgui N , Vandenberghe F, Delacretaz A, Quteineh L, Choong E, Gholamrezaee M, Magistretti P, Aubry JM, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Kutalik Z, Conus P, Eap CB. Association of PCK1 with body mass index and other metabolic features in patients with psychotropic treatments . J Clin Psychopharmacol. 2015 Oct;35(5):544-52. doi: 10.1097/JCP.0000000000000388
Delacretaz A, Preisig M, Vandenberghe F, Saigi-Morgui N , Quteineh L, Choong E, Gholamrezaee M, Kutalik Z, von Gunten A, Castelao E, Vollenweider P, Conus P, Eap C. Influence of MCHR2 and MCHR2-AS1 genetic polymorphisms on body mass index in psychiatric patients and in subjects from the general population with present or past atypical depression . Presented at the 2015 World Congress of Biological Psychiatry; June 18, 2015. Athens, Greece.
Saigi-Morgui N , Vandenberghe F, Delacretaz A, Quteineh L, Gholamrezaee M, Kutalik Z, Aubry JM, von Gunten A, Conus P, Eap C. Influence of weighted genetic risk score on BMI in Swiss psychiatric cohorts . Presented at the 2015 World Congress of Biological Psychiatry; June 14, 2015. Athens, Greece.
Quteineh L, Vandenberghe F, Saigi-Morgui N , Delacretaz A, Choong E, Gholamrezaee M, von Gunten A, Preisig M, Castelao E, Vollenweider P, Kutalik Z, Conus P, Eap C. Impact of HSD11B1 polymorphisms on body mass index and components of the metabolic syndrome in patients with psychotropic treatments . Presented at the 2015 World Congress of Biological Psychiatry; June 2015. Athens, Greece.
Quteineh L, Vandenberghe F, Saigi Morgui N , Delacretaz A, Choong E, Gholam-Rezaee M, Magistretti P, Bondolfi G, von Gunten A, Preisig M, Castelao E, Vollenweider P, Waeber G, Bochud M, Kutalik Z, Conus P, Eap CB. Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments . Pharmacogenet Genomics. 2015 May;25(5):246-58. doi: 10.1097/FPC.0000000000000131
Benson C, Chirila C , Graham J , Radder C, Zheng Q, Muser E, Woodruff K. Health resource use and cost analysis of schizophrenia patients participating in a randomized, multicenter, double-blind, relapse prevention study of paliperidone palmitate 3-month formulation . Poster presented at the 2015 ISPOR 20th Annual International Meeting; May 2015. Philadelphia, PA.
Rothman KJ . Persons at high risk of cancer. An approach to cancer etiology and control. In: Fraumeni J Jr, editor, editors. Alcohol . New York: NY. Academic Press; 1975.